Baxdrostat (Aldosterone Synthase Inhibitor)

Type: drug

Status: Investigational

Developer: CinCor Pharma/AstraZeneca

Breakthrough Summary

No summary available.

Mechanism of Action

Selective aldosterone synthase inhibitor for resistant hypertension

Year: 2025-2026